LobbyingChristianacare lobbying by quarter
Christianacare's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Christianacare
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $28.9K | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $5,807 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $8,000 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$14.6K · 15 reports
- Medicare and Medicaid$14.6K · 15 reports
- Budget and appropriations$13.5K · 10 reports
- Pharmacy$3,833 · 11 reports
- Immigration$2,495 · 4 reports
- Labor, antitrust and workplace$1,333 · 4 reports
- Trade$1,161 · 2 reports
- Telecommunications$1,161 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseChristianacare | $52.7K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/25for Q2 | In-house | Under $5,000 |
| 07/15for Q2 | In-house | Under $5,000 |
| 04/20for Q1 | In-house | Under $5,000 |
| 01/20for Q4 2025 | In-house | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | $10K |
| 25/07/18for Q2 2025 | In-house | Under $5,000 |
| 25/03/26for Q1 2025 | In-house | $8,000 |
| 25/01/21for Q4 2024 | In-house | Under $5,000 |
| 24/10/21for Q3 2024 | In-house | Under $5,000 |
| 24/07/19for Q2 2024 | In-house | Under $5,000 |
| 24/04/22for Q1 2024 | In-house | $5,807 |
| 24/01/19for Q4 2023 | In-house | Under $5,000 |
| 23/10/19for Q3 2023 | In-house | Under $5,000 |
| 23/07/20for Q2 2023 | In-house | Under $5,000 |
| 23/04/19for Q1 2023 | In-house | Under $5,000 |
| 23/01/20for Q4 2022 | In-house | $28.9K |